capecitabine
Showing 26 - 50 of 1,000
Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)
Active, not recruiting
- Colo-rectal Cancer
- Metastatic Cancer
- Regorafenib
- +3 more
-
Besançon, France
- +2 more
Jan 24, 2023
Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract
Recruiting
- Biliary Tract Neoplasms
- +3 more
- S-1
- Capecitabine
-
Shanghai, ChinaHuashan hospital
Aug 16, 2022
Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)
Not yet recruiting
- Gastric Cancer
- RC48-ADC
- +4 more
-
Beijing, ChinaBeijing Cancer Hospital
Aug 7, 2023
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)
Not yet recruiting
- Locally-advanced Rectal Cancer
- mFOLFIRINOX
- +6 more
-
Lyon, Rhöne, France
- +1 more
Jun 12, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)
Recruiting
- Nasopharyngeal Carcinoma
- Sintilimab
- Capecitabine
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022
RECTAL CANCER Trial in Faenza (Capecitabine, Radiotherapy, Durvalumab)
Recruiting
- RECTAL CANCER
- Capecitabine
- +2 more
-
Faenza, ItalyOspedale Degli Infermi Uo Oncologia
Jul 19, 2022
Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ivaltinostat
- Capecitabine
- (no location specified)
Feb 10, 2022
Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)
Terminated
- Head and Neck Squamous Cell Carcinoma
- Capecitabine
- +3 more
-
Norfolk, Nebraska
- +2 more
Aug 10, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Pseudomyxoma Peritonei Trial in Milano (Capecitabine)
Recruiting
- Pseudomyxoma Peritonei
- Capecitabine
-
Milano, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022
Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1
Recruiting
- Radiotherapy
- +3 more
- SBRT radiotherapy + Conventionally fractionated radiotherapy
- +2 more
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)
Not yet recruiting
- Triple-negative Breast Cancer
- chidamide
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 25, 2022
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
- GZ17-6.02
- Capecitabine
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)
Active, not recruiting
- Elderly Metastatic Colorectal Cancer Patients
- Capecitabine
- +2 more
-
Padua, ItalyIstituto Oncologico Veneto IRCCS
Mar 30, 2022
Breast Cancer, Chemo Effect Trial (Capecitabine)
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Capecitabine
- (no location specified)
Mar 9, 2022
Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)
Active, not recruiting
- Glioblastoma
- Capecitabine
- Bevacizumab
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022
Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Feb 10, 2022
Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)
Recruiting
- Triple-negative Breast Cancer
- Chiauranib
- capecitabine
-
Guangzhou, Guangdong, China
- +3 more
Apr 14, 2022
Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and
Not yet recruiting
- Invasive Mammary Carcinoma
- Metastatic Breast Cancer
- Capecitabine
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jan 11, 2023
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022